| Name | Title | Contact Details |
|---|---|---|
Manuel Monge |
Vice President Human Resources | Profile |
Joseph Lingle |
Vice President, Human Resources | Profile |
Damaris Cadawallader |
Director, Human Resources | Profile |
Dipen Desai |
Vice President, Complex Product R&D | Profile |
Bhavika Patel |
Director Analytical R&D | Profile |
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm`s SINE compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm`s lead compound, XPOVIO™ (selinexor), received accelerated approval from the FDA in July 2019 in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. A Marketing Authorization Application for selinexor is also currently under review by the European Medicines Agency. In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development.
AN2 Therapeutics is a biopharmaceutical company that develops therapies to treat rare, chronic, and serious infectious diseases in areas of high unmet medical need.
Immtech Pharmaceuticals is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our team of orthopedic surgeons and physical therapists serve Jacksonville, Orange Park and St. Augustine. We offer expert care for bones, muscles, and joints. Call (904) 634-0640 for an appointment!
Youth Home, Inc. is a non-profit psychiatric treatment center located in Little Rock, Arkansas for emotionally troubled adolescents and their families.